Clinical Trial Update: Testing SIROLIMUS in Beta-thalassemia Transfusion Dependent Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update for sirolimus in transfusion-dependent beta-thalassemia patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Rare Partners srl Impresa Sociale | Conditions: Beta-Thalassemia | Phase 2 | Status: COMPLETED